trending Market Intelligence /marketintelligence/en/news-insights/trending/V64nXREnIC-Q4heYSj_51Q2 content esgSubNav
In This List

Teva Pharmaceutical director resigns

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Teva Pharmaceutical director resigns

Yitzhak Peterburg resigned as a director of Teva Pharmaceutical Industries Ltd., effective Dec. 12.

Peterburg is the former interim president and CEO of the company. He resigned for personal reasons and not because of any disagreement with Teva.